Author:
Tang Hung-Jen,Lai Chih-Cheng
Reference6 articles.
1. Ceftolozane–tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial;Kollef;Lancet Infect Dis,2019
2. A randomized trial of 7-day doripenem versus 10-day imipenem–cilastatin for ventilator-associated pneumonia;Kollef;Crit Care,2012
3. Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study;Réa-Neto;Curr Med Res Opin,2008
4. Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: a multicenter, randomized study;Chastre;Crit Care Med,2008
5. A PROspective study on the usage patterns of doripenem in the Asia-Pacific region (PROUD study);Mustafa;Int J Antimicrob Agents,2014
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献